Classical Hodgkin Lymphoma; Real-World Observations from Physicians, Patients, and Caregivers on the Disease and Its Treatment (CONNECT)-a Cross-Sectional Survey of Patients with Stage III or IV Classical Hodgkin Lymphoma Compared By Age

被引：1
|
作者：
Flora, Darcy R. [1 ]
Parsons, Susan K. [2 ]
Liu, Nicholas [3 ]
Yu, Kristina S. [3 ]
Holmes, Katie [4 ]
Flores, Carlos [5 ]
Fanale, Michelle A. [3 ]
Kumar, Supriya [4 ]
Surinach, Andy [5 ]
Byrd, Rachel [1 ]
Evens, Andrew M. [6 ]
机构：
[1] GRYT Hlth, Rochester, NY USA
[2] Tufts Med Ctr, Div Hematol Oncol, Boston, MA USA
[3] Seagen Inc, Bothell, WA USA
[4] Ipsos Healthcare, New York, NY USA
[5] Genesis Res, Hoboken, NJ USA
[6] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-147354
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1966
引用
收藏
页码：1966 / +
页数：4
相关论文
共 50 条
  • [21] Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China
    Qing Wen
    Jingjing Ge
    Yaxin Lei
    Yue Zhang
    Xiaoshuang Kong
    Wenhua Wang
    Huting Hou
    Zeyuan Wang
    Siyu Qian
    Mengjie Ding
    Meng Dong
    Linan Zhu
    Mingzhi Zhang
    Xudong Zhang
    Qingjiang Chen
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3989 - 4003
  • [22] Real-world treatment management of patients with advanced-stage classic Hodgkin lymphoma receiving front line therapy
    Avigdor, A.
    Trinchese, F.
    Gavini, F.
    Bent-Ennakhil, N.
    Dalal, M.
    Zomas, A.
    Broun, S. Gettner
    Gini, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S649 - S650
  • [23] Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China
    Wen, Qing
    Ge, Jingjing
    Lei, Yaxin
    Zhang, Yue
    Kong, Xiaoshuang
    Wang, Wenhua
    Hou, Huting
    Wang, Zeyuan
    Qian, Siyu
    Ding, Mengjie
    Dong, Meng
    Zhu, Linan
    Zhang, Mingzhi
    Zhang, Xudong
    Chen, Qingjiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3989 - 4003
  • [24] Real-World Characteristics of Patients with Classical Hodgkin Lymphoma Receiving Frontline Brentuximab Vedotin with Chemotherapy: A Retrospective Analysis with Propensity Score Matching
    Phillips, Tycel J.
    Yu-Isenberg, Kristina
    Liu, Nicholas
    Surinach, Andy
    Flores, Carlos
    Lisano, Julie
    Fanale, Michelle A.
    Burke, John M.
    BLOOD, 2020, 136
  • [25] Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States
    Winter, Allison
    Liu, Nicholas
    Surinach, Andy
    Fanale, Michelle
    Yu, Kristina S.
    Narkhede, Mayur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 527 - 534
  • [26] PATIENT CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS WITH MANTLE CELL LYMPHOMA IN SPAIN: A REAL-WORLD, CROSS-SECTIONAL STUDY
    Esteban-Burgos, L.
    Molero, A.
    Varea, R.
    Cerezo, Diaz S.
    Milloy, N.
    Kiran, A.
    VALUE IN HEALTH, 2023, 26 (12) : S24 - S24
  • [27] Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database
    Bates, James E.
    Dhakal, Sughosh
    Mazloom, Ali
    Casulo, Carla
    Constine, Louis S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (02) : 325 - 330
  • [28] Brentuximab Vedotin With Chemotherapy for Patients With Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 15 - 16
  • [29] Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study
    Straus, David J.
    Dlugosz-Danecka, Monika
    Connors, Joseph M.
    Illes, Arpad
    Picardi, Marco
    Lech-Maranda, Ewa
    Feldman, Tatyana
    Smolewski, Piotr
    Savage, Kerry J.
    Bartlett, Nancy L.
    Walewski, Jan
    Ramchandren, Radhakrishnan
    Zinzani, Pier Luigi
    Hutchings, Martin
    Munoz, Javier
    Kim, Won Seog
    Advani, Ranjana
    Ansell, Stephen M.
    Younes, Anas
    Gallamini, Andrea
    Liu, Rachael
    Little, Meredith
    Fenton, Keenan
    Fanale, Michelle A.
    Radford, John A.
    BLOOD, 2020, 136
  • [30] Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study
    Ramchandren, Radhakrishnan
    Dlugosz-Danecka, Monika
    Connors, Joseph M.
    Radford, John
    Illes, Arpad
    Picardi, Marco
    Lech-Maranda, Ewa
    Feldman, Tatyana
    Smolewski, Piotr
    Savage, Kerry J.
    Bartlett, Nancy L.
    Walewski, Jan
    Zinzani, Pier Luigi
    Hutchings, Martin
    Munoz, Javier
    Kim, Won Seog
    Advani, Ranjana
    Ansell, Stephen M.
    Gallamini, Andrea
    Alekseev, Sergey
    Lee, Hun Ju
    Liu, Rachael
    Little, Meredith
    Fenton, Keenan
    Fanale, Michelle
    Straus, David J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S371 - S371
12345